Cargando…

Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience

PURPOSE: The use of radiation therapy (RT) in consolidating oligometastatic prostate cancer (OPCa) is a rapidly evolving treatment paradigm. We review our institutional experience using metastasis-directed therapy in the definitive management of men with OPCa. METHODS AND MATERIALS: Patients with OP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deek, Matthew P., Yu, Colburn, Phillips, Ryan, Song, Daniel Y., Deville, Curtiland, Greco, Stephen, DeWeese, Theodore L., Antonarakis, Emmanuel S., Markowski, Mark, Paller, Channing, Denmeade, Samuel, Carducci, Michael, Walsh, Patrick C., Pienta, Kenneth J., Eisenberger, Mario, Tran, Phuoc T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050213/ https://www.ncbi.nlm.nih.gov/pubmed/31419509 http://dx.doi.org/10.1016/j.ijrobp.2019.08.008

Ejemplares similares

Patterns of recurrence and modes of progression after metastasis-directed therapy in oligometastatic castration-sensitive prostate cancer
por: Deek, Matthew P., et al.
Publicado: (2020)

A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE)
por: Radwan, Noura, et al.
Publicado: (2017)

Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial
por: Phillips, Ryan, et al.
Publicado: (2020)

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)
por: Hasan, Hamza, et al.
Publicado: (2020)

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
por: Kapoor, Roche, et al.
Publicado: (2019)

An Integrated Program in a Pandemic: Johns Hopkins Radiation Oncology Department
por: Wright, Jean L., et al.
Publicado: (2020)

End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer
por: Narang, Amol K., et al.
Publicado: (2017)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

Johns Hopkins Hospital
Publicado: (1914)

The Johns Hopkins Hospital Reports
por: Struthers, J. W.
Publicado: (1904)

The Johns Hopkins Hospital Reports
Publicado: (1894)

The Johns Hopkins Hospital Reports
Publicado: (1894)

Johns Hopkins Hospital Reports
por: Miles, Alexander
Publicado: (1903)

The Johns Hopkins Hospital Reports
Publicado: (1900)

The Johns Hopkins Hospital Reports
Publicado: (1892)

The Johns Hopkins Hospital Reports
Publicado: (1893)

The Johns Hopkins Hospital Reports
por: Lockwood, C. B.
Publicado: (1900)

The Johns Hopkins Hospital Reports
por: Leith, R. F. C.
Publicado: (1901)

The Johns Hopkins Hospital Reports
Publicado: (1893)

Johns Hopkins Hospital Reports
Publicado: (1894)

The Johns Hopkins Hospital Reports
Publicado: (1896)

The Johns-Hopkins Hospital Reports
Publicado: (1896)

Appropriation for the John Hopkins University
Publicado: (1899)

The Johns Hopkins Hospital Reports
Publicado: (1900)

Johns Hopkins Hospital Reports
Publicado: (1896)

The Johns Hopkins Hospital Reports
Publicado: (1903)

The Johns Hopkins Hospital Reports
Publicado: (1901)

Biology and Johns Hopkins University
Publicado: (1881)

Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials
por: Deek, Matthew P., et al.
Publicado: (2022)

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited
por: Deek, Matthew P., et al.
Publicado: (2021)

Johns Hopkins, Ginecología y obstetricia
Publicado: (2005)

Johns Hopkins, Ginecología y obstetricia /
Publicado: (2005)

Medical Women at the Johns Hopkins University
Publicado: (1891)

The Medical Department of Johns Hopkins University
Publicado: (1907)

The Johns Hopkins Hospital of Baltimore City
Publicado: (1877)

Altering the Natural History of Oligometastatic Prostate Cancer With Local Therapies: Reality Versus Illusion
por: Tran, Phuoc T., et al.
Publicado: (2017)

Science at the bedside: the footprints of Yale and Johns Hopkins.
por: McGehee Harvey, A.
Publicado: (1979)

The Johns Hopkins Hospital Reports: Volume VI
Publicado: (1898)

Bipolar androgen therapy (BAT): A patient's guide
por: Denmeade, Samuel, et al.
Publicado: (2022)

Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins Experience
por: Khalafallah, Adham M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pro3o2ifvqd094e0rn48s18dul